Summary The coronavirus disease 2019 (COVID‐19) pandemic is a rapidly evolving global
emergency that continues to strain healthcare systems. Emerging research describes a …

Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus-2 (SARS-CoV-2), has become a global epidemic and poses a major …

This review evaluates the ability of the fibrosis index based on four factors (FIB-4) identifying
fibrosis stages, long-time prognosis in chronic liver disease, and short-time outcomes in …

Importance The rapid pandemic expansion of the disease caused by the new SARS-CoV-2
virus has compromised health systems worldwide. Knowledge of prognostic factors in …

Abstract Introduction and Objectives Liver function tests (LFT) abnormalities are reported in
up to 50% of COVID-19 patients, and metabolic comorbidities are associated with poorer …

OBJECTIVE: Liver involvement of SARS-CoV-2 infection has been reported in several
papers, but without homogeneous findings. We aimed to systematically review the …

Abstract The coronavirus disease 2019 (COVID-19) represents a global health and
economic challenge. Hepatic injuries have been approved to be associated with severe …

Coronavirus disease 2019 (COVID‐19) is associated with adverse outcomes, including
need for invasive mechanical ventilation and death in people with risk factors. Liver enzyme …

Background Studies on a new coronavirus disease (COVID-19) show the elevation of liver
enzymes and liver fibrosis index (FIB-4) independently on pre-existing liver diseases. It …

Abstract The Fibrosis-4 Index (FIB-4), developed to predict fibrosis in liver disease, was used
to identify patients with coronavirus disease 2019 who will require ventilator support as well …